Presentation is loading. Please wait.

Presentation is loading. Please wait.

Driving Innovation Supporting innovation in industrial biotechnology in the UK Merlin Goldman.

Similar presentations


Presentation on theme: "Driving Innovation Supporting innovation in industrial biotechnology in the UK Merlin Goldman."— Presentation transcript:

1 Driving Innovation Supporting innovation in industrial biotechnology in the UK Merlin Goldman

2 Driving Innovation What is the Technology Strategy Board? We are a national body set up to invest in business innovation We work across business, universities and government We mostly come from business We are responsible for investing nearly £400m a year

3 Driving Innovation Investment Targets

4 Driving Innovation The Toolset Feasibility & Collaborative R&D Feasibility & Collaborative R&D Smart Launchpad

5 Driving Innovation Why Industrial Biotechnology UK is the 7 th largest producer of chemicals with sales of £60bn per year. UK has a strong underpinning capability in the biosciences e.g. the UK is ranked third globally for citation impact in the biological sciences Industrial biotechnology poses a significant opportunity for the UK’s chemical sector to maintain and increase its competitiveness in these global markets. Growing market: £150bn and £360bn by 2025, with the opportunity for the UK between £4bn and £12bn. Sustainable: industrial biotechnology can help to reduce CO 2 release; in 2009, the World Wildlife Fund put this figure at 2.5 billion tons by 2030.

6 Driving Innovation Investments so far 3 specific competitions –Over £7m invested –Funding 34 feasibility projects –Funding 8 collaborative R&D projects Working with the Research Councils on joint funding activities –ERANET Bioenergy –ERANET Industrial Biotechnology Knowledge Exchange –Industrial Biotechnology Special Interest Group (IB-SIG) –Events

7 Driving Innovation Industrial Biotechnology Special Interest Group Challenges include reducing costs and producing greener chemicals but many not aware that industrial biotechnology may be the solution for them IB-SIG 1. Chemistry Innovation KTN - UK target list 2. Biosciences KTN - available technology /science providers 3. Make 1:1 visits to chemical companies 4. Run networking events, including Norwegian organisations

8 Driving Innovation Ingenza and Lucite International in multi-year bioprocess development agreement Synthetic biology and bioprocess development platforms Manufacture of industrial polymers, including acrylic Annual turnover: £885m

9 Driving Innovation Online Portal Over 700 members Regular Newsletters

10 Driving Innovation Why a bilateral with Innovation Norway? Take risks, try new ways to promote innovation Culture, tradition, complementarities Businesses (and academics) wanted it Feasible knowledge exchange implementation Now part of our Corporate Strategy Success has led to us repeating the competition activity on water technologies with Israel

11 Driving Innovation Diameter: 1,385 km Volume: 1,386 million km3

12 Driving Innovation Producing High Value Chemicals (HVC 3) 5 feasibility and 4 collaborative R&D (cR&D) approved - £1.8m £400k from Innovation Norway Feasibility (£0.4m) High scores >70% GlycoMar & MicroA; Centre for Process Innovation Limited (CPI) & Marine BioProducts; Biocatalysts & University of Manchester; C-Tech Innovation & AMTech & Ingenza; Aquapharm Biodiscovery & Aqua Bio Technology cR&D (£1.4m) Higher scores: 75-85% Ingenza & Lucite; Unilever & Croda & Borregaard; Chirotech & Biotica x 2

13 Driving Innovation Marine Bioprocessing of sustainable marine resources for the production of high value chemicals Testing of a fish by-product as a fermentation supplement £200k –HVM Catapult –Marine Bioproducts

14 Driving Innovation Production of natural marine functional ingredients for skin care Identify natural marine ingredients that could replace the petroleum-based components used extensively within the skincare market £195k –Aquapharm –AquaBioTechnology

15 Driving Innovation Pilot scale production of a biologically active polysaccharide from a marine microalgae using photobioreactor technology To determine whether an identified polysaccharide can be produced at pilot scale in an algal bioreactor system £160k –Glycomar –MicroA

16 Driving Innovation Engineering Cellulose using Biotechnology Cellulose is used in various cosmetic products, creams and lotions, where its good binding, thickening and stabilising properties are utilised £890k –Unilever –Borregaard –Croda

17 Driving Innovation Next Investment through Competition High Value Chemicals 4 – approved Due to launch in October 2012 Budget £2.5m from Technology Strategy Board Will have co-funding from Innovation Norway

18 Driving Innovation Thank you.


Download ppt "Driving Innovation Supporting innovation in industrial biotechnology in the UK Merlin Goldman."

Similar presentations


Ads by Google